WASHINGTON, D.C. — U.S. Senator Tommy Tuberville introduced the Homeopathic Drug Product Safety, Quality, and Transparency Act. Senator Mike Lee co-sponsored the legislation, which proposes creating a distinct regulatory pathway for homeopathic products at the Food and Drug Administration (FDA).
This proposed pathway would exempt homeopathic products from the FDA approval process used for traditional pharmaceuticals. The legislation designates homeopathic drug products as a distinct category with specific safety, labeling, and manufacturing standards.
The FDA first recognized homeopathic medicines in 1938 and regulated them under a specific framework until 2019. In 2019, the FDA withdrew its regulatory framework for these products.
Tuberville said, "I have long been an advocate for homeopathic medicine." He said, "The reality is that too many Americans today are hooked on pharmaceuticals when they could be using homeopathic remedies, which are often cheaper and can yield miraculous results." He added, "There's no reason why the FDA shouldn't be reviewing and approving some of these remedies to help Americans live healthier lives." Several organizations endorsed the legislation, including MAHA Action, the CPAC Foundation, Americans for Homeopathy Choice Action, the National Health Federation, the Health Freedom Defense Fund, and the Natural Products Association.
No independent assessment of Tommy Tuberville’s claims was available.